Q4 2025 · 13F-HR
Empery Asset Management, LPholdings as filed
Filed 2026-02-11 · accession 0000902664-26-000854
$113.4M
Reported value
31
Positions
2025-12-31
Period end
The Brief · Empery Asset Management, LP · Q4 2025
AI · grounded in 13F
Empery Asset Management, LP established a new position in X4 Pharmaceuticals Inc XFOR worth $35.8M. The fund also added new stakes in Immuneering Corp IMRX for $17.6M and Empery Digital Inc EMPD for $13.4M. These additions occurred alongside the closure of several small positions, including 89BIO INC ETNBGBP and UNITY BIOTECHNOLOGY INC UNBX.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 98420X202 | XFOR | X4 Pharmaceuticals Inc | $35.8M | 31.6% | 8,951,105 | Common | SOLE |
| 45254E107 | IMRX | Immuneering Corp | $17.6M | 15.5% | 2,674,950 | Common | SOLE |
| 92864V608 | EMPD | Empery Digital Inc | $13.4M | 11.8% | 2,930,345 | Common | SOLE |
| Y3894J187 | IMPP | Imperial Pete Inc | $11.5M | 10.2% | 3,182,951 | Common | SOLE |
| 74019P207 | DTIL | Precision BioSciences Inc | $9.1M | 8.05% | 2,194,635 | Common | SOLE |
| 007408206 | ADUR | Aduro Clean Technologies Inc | $5.9M | 5.22% | 571,046 | Common | SOLE |
| 87990A106 | TNYA | Tenaya Therapeutics Inc | $3.9M | 3.40% | 5,414,101 | Common | SOLE |
| G2662B103 | CRML | Critical Metals Corp | $3.4M | 3.01% | 491,460 | Common | SOLE |
| 29415C101 | EOSE | Eos Energy Enterprises Inc | $2.9M | 2.52% | 249,726 | Common | SOLE |
| 86889P208 | SRZN | Surrozen Inc | $2.3M | 2.07% | 103,974 | Common | SOLE |
| 00444T209 | TLPH | Talphera Inc | $1.5M | 1.34% | 1,333,497 | Common | SOLE |
| 48669G303 | KZIA | Kazia Therapeutics Ltd | $1.2M | 1.03% | 170,000 | Common | SOLE |
| 74319B502 | PROF | Profound Med Corp | $1.1M | 1.00% | 143,532 | Common | SOLE |
| Y73118112 | RBNE | Robin Energy Ltd | $882,141 | 0.78% | 301,072 | Common | SOLE |
| 86804F400 | SLE | Super League Enterprise Inc | $763,118 | 0.67% | 1,249,989 | Common | SOLE |
| 98422T100 | XLO | Xilio Therapeutics Inc | $757,382 | 0.67% | 1,183,040 | Common | SOLE |
| 08205P209 | BNTC | Benitec Biopharma Inc | $746,777 | 0.66% | 55,440 | Common | SOLE |
| 107930117 | BCTXZ | Briacell Therapeutics Corp | $193,314 | 0.17% | 666,600 | Common | SOLE |
| 02008G201 | ALUR | Allurion Technologies Inc | $73,654 | 0.06% | 59,881 | Common | SOLE |
| 74365U107 | TARA | Protara Therapeutics Inc | $68,395 | 0.06% | 12,832 | Common | SOLE |
| 67092M125 | NTRBW | Nutriband Inc | $64,751 | 0.06% | 40,218 | Common | SOLE |
| G7490F127 | RTACW | Renatus Tactical Acquis | $40,635 | 0.04% | 50,000 | Common | SOLE |
| M74240116 | NRSNW | Neurosense Therapeutics Ltd | $36,145 | 0.03% | 100,402 | Common | SOLE |
| M68057112 | MTEKW | Maris Tech Ltd | $35,712 | 0.03% | 297,600 | Common | SOLE |
| 86887P119 | BNCWW | CEA Industries Inc | $27,650 | 0.02% | 500,000 | Common | SOLE |
| 65344E115 | NXGLW | Nexgel Inc | $21,600 | 0.02% | 90,000 | Common | SOLE |
| 84757T113 | MDAIW | Spectral AI Inc | $15,001 | 0.01% | 33,336 | Common | SOLE |
| 74623V111 | PCTTW | Purecycle Technologies Inc | $11,149 | 0.01% | 14,477 | Common | SOLE |
| 58471K111 | MDCXW | Medicus Pharma Ltd | $9,680 | 0.01% | 12,100 | Common | SOLE |
| G3302D111 | FGIWW | FGI Industries Ltd | $4,196 | 0.00% | 83,928 | Common | SOLE |
| M61472110 | NEXRW | Jeffs Brands Ltd | $4,111 | 0.00% | 360,577 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.